Cargando…
Somatostatin receptor based PET/CT in patients with the suspicion of cardiac sarcoidosis: an initial comparison to cardiac MRI
Diagnosis of cardiac sarcoidosis is often challenging. Whereas cardiac magnetic resonance imaging (CMR) and positron emission tomography/computed tomography (PET/CT) with (18)F-fluorodeoxyglucose (FDG) are most commonly used to evaluate patients, PET/CT using radiolabeled somatostatin receptor (SSTR...
Autores principales: | Lapa, Constantin, Reiter, Theresa, Kircher, Malte, Schirbel, Andreas, Werner, Rudolf A., Pelzer, Theo, Pizarro, Carmen, Skowasch, Dirk, Thomas, Lena, Schlesinger-Irsch, Ulrike, Thomas, Daniel, Bundschuh, Ralph A., Bauer, Wolfgang R., Gärtner, Florian C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363622/ https://www.ncbi.nlm.nih.gov/pubmed/27780922 http://dx.doi.org/10.18632/oncotarget.12799 |
Ejemplares similares
-
Cardiovascular magnetic resonance imaging and clinical performance of somatostatin receptor positron emission tomography in cardiac sarcoidosis
por: Pizarro, Carmen, et al.
Publicado: (2017) -
Peptide receptor radionuclide therapy as a new tool in treatment-refractory sarcoidosis - initial experience in two patients
por: Lapa, Constantin, et al.
Publicado: (2018) -
Novel Noninvasive Nuclear Medicine Imaging Techniques for Cardiac Inflammation
por: Kircher, Malte, et al.
Publicado: (2017) -
In-Vivo Somatostatin-Receptor Expression in Small Cell Lung Cancer as a Prognostic Image Biomarker and Therapeutic Target
por: Şen, Feyza, et al.
Publicado: (2023) -
Somatostatin receptor expression in small cell lung cancer as a prognostic marker and a target for peptide receptor radionuclide therapy
por: Lapa, Constantin, et al.
Publicado: (2016)